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"In the emplonnent setting, discrimination among individuals has long been legally, ethicalh-, and socially acceptable" (1 ).
Employers may select prospective employees
on the basis of their past experience or their
education but are prohibited from selecting
employees on the basis of specific categories
such as age. color. and ethnic origin (1 ).
Now there are numerous reasons for employers to expand the selection process to include genetic information. Employers are
increasingly concerned about the spiraling
cost of health insurance as well as the possibility of genetic susceptibility to illness
caused by exposure to workplace toxins (2).
The use of genetic information in the
workplace roses societal risks that have an
impact on emplO\·ment possibilities, health
insurance, and rrivacy. Individuals who
might otherwise believe that they can benefit from genetic testing may decline it beThe authors are membe<s of the Committee on Genetic
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cause of thetr fear of employment discrimination and lack of privacy in the workplace
(3). As a consequence, the future of research on the benefits and risks of predictive genetic testing may also be compromised (4). Thus, policy-makers need to
evaluate legislative and regulatory strategies
to address these concerns.
The Hereditary Susceptibility Working
Group of the National Action Plan on
Breast Cancer (NAPBC). coordinated by
the PHS Office on Women's Health (5),
recently joined with the National Institutes
of Health-Department of Energy (NIHDOE) Working Group on Ethical, Legal and
Social Implications of Human Genome Research (the ELSI Working Group) (6) to
address the issue of genetic information in
the workplace. This commitment builds on
their combined efforts to first address the use
of, misuse of, and access to genetic information in the health insurance context, and
then to focus on these concerns in the workplace. Obviously, the fears of discrimination
in health insurance and employment are intertwined. Without a job, most people in our
country do not have health insurance. Yet
genetic information in the workplace poses
unique challenges. Employers in most jurisdictions are not prohibited from requiring
genetic testing, even though there is insufficient evidence to justify the use of any
existing test for genetic susceptibility as a
basis for employment decisions. Even if
employers do not use genetic testing, they
still may have access to the medical
records of their employees and prospective
employees, and thus will be able to find
out if these individuals have cenain predispositions to disease. Employers may be
reluctant to hire or promote individuals
they believe will become prematurely unable to work (2). Thus, legislative and
regulatory strategies to address discrimination and privacy concems in the workplace should be considered along with the
NAPBC and ELSI Working Group recommendations on genetic information and
health insurance that were promulgated
and disseminated in 1995 (7, 8).

Evolution of State Legislation
The first law addressing genetic discrimination in the workplace was enacted in 1975
when North Carolina passed legislation
prohibiting employers from discriminating
against any person possessing the traits for
sickle cell or hemoglobin C (9). Over the
next decade, four other states passed laws
prohibiting employment discrimination
based on the sickle cell trait, other specified
traits, and carrier status (10). In 1989, Oregon added "genetic screening" to an existing law that made it unlawful for an employer to subject an employee or prospective employee to different types of tests,
including breathalyzers and polygraphs
( 11 ). Although this law did not include a
definition for genetic screening, it was the
first state law to go beyond specific traits
and disorders.
More comprehensive legislation emerged
in 1991, when Wisconsin prohibited work-.
place discrimination, prohibited employer
access to genetic test results, and provided
privacy protections for employees ( 12). This
legislation addressed not only employers but
also labor organizations, employment agencies, and licensing agencies. The focus of the
legislation was on genetic testing and not on
the use of genetic information derived from
phenotype indicators and family history.
This Wisconsin legislation provides for genetic testing of an employee if the employee
requests the test. The law also requires written and informed consent and specifies that
no adverse action may be taken against the
employee as a result of the test. This employee testing may only be conducted for the
purpose of investigating a workers' compensation claim or to determine the employee's
susceptibility or level of exposure to toxic
chemicals in- the workplace. Wisconsin's
criminal code-specifically makes it unlawful
to disclose genetic test information without
the written and informed consent of the
individual (13).
Thus, the Wisconsin approach attempts
to integrate protection against discrimination in employment with some privacy protection. Similar approaches have been incorporated to varying degrees in recent legislation passed in Iowa (14), Rhode Island
(15), New Hampshire (16), New York (17),
and Oregon (18).This trend parallels similar state initiatives in the health insurance
context (7, 8).
In 1996, New Jersey enacted comprehensive legislation that prohibits employment discrimination based on genetic information (19). Thus, New Jersey does not
focus on genetic testing alone but expands
the prohibition to include discrimination
on the basis of "information about genes,
gene products or inherited characteristics
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that may deri,-e from an individual or family member'' (19, 20). New Jersey also prohibits retaliation by employers if an employee or prospecri,-e employee refuses to take a
genetic test or reveal the results of a genetic
test (19).
In contrast. ~ew York law specifies that
the emplo\·er rna\· '' ... require a specified
genetic test as a condition of employment
where such a test is shown to be directly
related to the occupational environment,
such that the emploYee or applicant with a
particular genetic anomaly might be at an
increased risk of disease as a result of working in said enYironment," but it is silent on
the need for the written and informed consent of the employee or applicant (17).
Even when stare la\vs require informed consent before genetic testing, they do not
address whether the informed consent process will pro\'ide notice that the test results
may be disclosed without authorization under certain circumstances, including paternity, criminal proceedings, or health department protocols.

Recent Federal Initiatives
In 1995. the Equal Employment Opportunity Commission \EEOC) issued a guidance
in its comrliance manual on the definition
of "disabilit\_., that addresses genetic discrimination in the workplace. It stated that
the Americans with Disabilities Act
(ADA) would rrotect individuals subjected
to discrimination on the "basis of genetic
information relating to illness, disease or
other disorders., ( 21 ). To further clarify its
position, it cites as an example an individual with a. positive predictive genetic test
for colon cancer as being subject to protection under the ADA if the employer "regards" the individual as having a disability
and has discriminated against the individual because of this perception. However, it is
not clear whether this coverage will extend
to unaffected individuals who are carriers of
recessive or X-linked mutations. To date,
there have been no genetic discrimination
complaints filed with the EEOC, and the
guidance has yet to be tested in court. Thus,
in the absence of judicial decisions, the
amount of protection actually provided by
the ADA remains limited.
Even though the ADA potentially offers
protection from discrimination, the focus of
the ADA is not the protection of an employee's privacy (22). Although the ADA
does prevent employers from making preemployment medical inquiries, it does not
prevent employers from obtaining medical
information, including genetic information,
after a conditional offer of employment.
Employers can require a preplacement medical exam, which may include a physical
1756

examination and blood tests (including genetic tests). They may also require a general
medical release of an individual's medical
records. Although an employer is prohibited from discriminating on the basis of a
disability, it is difficult for the individual to
prove that he or she did not get a job or
promotion, for example. because of disability or other genetic information ( 1).
In 1996, Congress passed the Health
Insurance Portability and Accountability
Act (23), which primarily applies to employer-based health insurance coverage and
was designed to allow workers w maintain
insurance coverage if they change or leave
their jobs. It pertains w employers who
provide health insurance coverage through
self-funded plans as well as through insurance companies, thus including those selffunded plans that have been beyond the
reach of state legislation because of the
Employee Retirement Income Security Act
(ERISA) preemption (24).
The law specifically prohibits a group
health insurance plan from using "genetic
information" to establish rules for eligibility or continued eligibility. It also provides
that genetic information shall not be
treated as a "preexisting condition in the
absence of the diagnosis of the condition
related to such information" (.23). However, the law does not provide any privacy
protections. The burden would be on the
employee to prove that the insurer did not
use genetic information to deny coverage
or affect the terms and conditions of
health coverage. Furthermore. it does not
prohibit group health plans from increasing rates, excluding all coverage for a particular condition, or imposing lifetime
caps on benefits as long as plan characteristics are not "directed at individual sick
employees or dependents" (23, 25).

Policy Implications
The development of public policy to address genetic information in the workplace
must be analyzed in light of the uncertainty
about the future scope and impact of genetic testing and the realities of the political
process. It also must be placed in context
with state and federal disability laws and
other genetic discrimination and privacy
legislation.
The primary legislative approach to addressing genetic information in the workplace is prohibition of employment discrimination. Although some state laws prohibit
employers from using the results of a chemical test of DNA or the protein product of a
gene, most of the laws do not expressly
prohibit employers from using phenotype
indicators, patterns of inheritance of genetic
characteristics, or requests for genetic test-

ing as a basis for discrimination. Although
some laws do attempt to prohibit both access to and use of genenc test results, others
provide for use of test results if the information is job-related. At the present time,
however, there is no scientific evidence to
link unexpressed genetic factors and the
ability to perform a job function. Therefore,
employers cannot prove that the use of genetic information is "job-related and consistent with business necessity," the standard
often applied in federal and state antidiscrimination laws (26). Furthermore, some
state laws provide for genetic testing by employers in order to determine an employee's
susceptibility to toxic chemicals or substances in the workplace, even though cleaning
up the environment would enhance the
working conditions for all employees and
would alleviate the need for genetic testing
of individual employees (28).
On the federal level, the ADA and the
Health Insurance Portability and Accountability Act of 1996 appear to offer limited
protection from discrimination but do not
prohibit employers and insurers from gaining access to genetic information. At
present, there is no uniform protection
against the use of, misuse of, and access to
genetic information in the workplace.
With these policy considerations in
mind, the Hereditar\' Susceptibility Working Group of the NAPBC and the ELSI
Working Group de,· eloped the following
recommendations for state and federal policy-makers (26, 27).
1) Employment organizations should be
prohibited from using genetic information
to affect the hiring of an individual or to
affect the terms, conditions, privileges, benefits, or termination of employment unless
the employment organization can prove
that this information is job related and
consistent with business necessity.
2) Employment organizations should be
prohibited from requesting or requiring collection or disclosure of genetic information
prior to a conditional offer of employment,
and under all other circumstances, employment organizations should be prohibited
from requesting or requiring collection or
disclosure of genetic information unless the
employment organization can prove this information is job related and consistent with
business necessity, or othenvise mandated
by law. Written and informed consent
should be required for each request, collection or disclosure.
3) Employment organizations should be
restricted from access to genetic information contained in medical records released
by individuals as a condition of empioyment, in claims filed for reimbursement of
health care costs, and other sources.
4) Employment organizations should be
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prohibited from releasing genetic information without prior written authorization of
the individual. Written authorization should
be required for each disclosure and include to
whom the disclosure will be made.
5) Violators of these provisions should
be subject to strong enforcement mechanisms, including a private right of action.
It is hoped that these recommendations
will stimulate a comprehensive approach
to addressing genetic privacy and discrimination in the workplace.
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